SCHEMBL4038458

SCHEMBL4038458

CC(C)c1ccc(C2c3ccc(O)cc3OC2(C)C)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.34
STS P08842 1/20 0.34
MAPT P10636 3/20 0.33
TMEM97 Q5BJF2 2/20 0.33
MEN1 O00255 2/20 0.33
THRB P10828 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TP53 P04637 1/20 0.33
HPGD P15428 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HTR2B P41595 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CYP3A4 P08684 1/20 0.33
ALOX15 P16050 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4043216 0.89 ESR1 (0.34) STSMAPTSMN1; SMN2TP53HPGD
SCHEMBL3592483 0.80 ABCB1 (0.38) MAPTMEN1THRBKMT2AKDM4E
SCHEMBL3603597 0.76 MAPT (0.33) MAPTTMEM97KDM4ESMN1; SMN2TP53
SCHEMBL3596490 0.75 MAPT (0.37) MAPTMEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL3592061 0.75 HTR2B (0.33) LMNAMAPTKDM4ESMN1; SMN2TP53
SCHEMBL9749008 0.71 TMEM97 (0.40) MAPTTMEM97KDM4ESMN1; SMN2TDP1
SCHEMBL2912988 0.68 AR (0.41) MEN1KMT2ATDP1
SCHEMBL3594648 0.68 DGAT1 (0.31) ALDH1A1
SCHEMBL3598445 0.68 HPGD (0.31) MAPTHPGD
Hydrochloric Acid SCHEMBL3599062 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1323716-B1 PROMOTERS FOR THE PROLIFERATION AND DIFFERENTIATION OF STEM CELLS AND/OR NEURON PRECURSOR CELLS TAKEDA PHARMACEUTICAL (JP) 2009-01-14 EP disclosed
US-20090012081-A1 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells TAKEDA PHARMACEUTICAL COMPANY LTD. (JP) 2009-01-08 US disclosed
US-7008950-B1 Benzofurans as suppressors of neurodegeneration TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2006-03-07 US disclosed
US-20040034049-A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-02-19 US disclosed
EP-1323716-A1 PROMOTERS FOR THE PROLIFERATION AND DIFFERENTIATION OF STEM CELLS AND/OR NEURON PRECURSOR CELLS Takeda Chemical Industries, Ltd. (JP) 2003-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012081-A1 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells NES, MKI67, CCNO LMNA 1938/4885STS 320/4885MAPT 4127/4885
US-20040034049-A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells NES, HAT1, PROX1 LMNA 1890/4885STS 589/4885MAPT 4443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.